Related Experiment Video
Updated: Jun 19, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
[Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy]
R Mignani1, S Feriozzi, G Carraro
1U.O. Nefrologia e Dialisi, Ospedale degli Infermi, Rimini, Italy. rmignani@auslrn.net
Abstract:
Renal involvement in Fabry's disease in males starts at an early age with microalbuminuria and proteinuria and progresses rapidly towards end-stage renal disease requiring dialysis or renal transplantation. Renal involvement, together with cardiac and cerebral damage, is responsible for the severe morbidity and mortality in patients with Fabry's disease. In heterozygous female patients renal involvement has also been documented, but the onset of renal damage occurs later and the progression to end-stage renal disease is slower. Considering the relevance of renal damage in the prognosis of Fabry's disease, it is mandatory to point out the diagnostic criteria of Fabry's nephropathy and the modalities of follow-up of patients with renal involvement. The aim of this study is also to provide recommendations regarding the diagnosis, follow-up and indication for enzyme replacement therapy in patients with Fabry's disease.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Lysosomal Hydrolases
Chronic Kidney Disease III: Interprofessional Care
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Endocarditis III: Medical Management
